CCBs probably leads to higher congestive heart failure compared with diuretic (moderate certainty).
CCBs showed no clear difference in cardiovascular mortality compared with diuretic (moderate certainty).
CCBs showed no clear difference in all‐cause mortality compared with β‐blocker (moderate certainty).
CCBs showed no clear difference in myocardial infarction compared with β‐blocker (moderate certainty).
CCBs probably leads to lower stroke compared with β‐blocker (moderate certainty).
CCBs showed no clear difference in congestive heart failure compared with β‐blocker (low certainty).
The intervention may leads to higher healing of rickets (number) Definition: normal alkaline phosphatase… (low certainty).
It is very uncertain whether the intervention changes morbidity (number) Definition: fractures (very low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The review found no eligible studies for this question.
Nimodipine showed no clear difference in death at the end of compared with placebo (moderate certainty).
Nimodipine showed no clear difference in recurrence of stroke at the end of compared with placebo (moderate certainty).
Nimodipine showed no clear difference in adverse events during treatment period compared with placebo (moderate certainty).
Nimodipine showed no clear difference in hypotension during treatment period compared with placebo (moderate certainty).
Nimodipine showed no clear difference in mean systolic blood pressure during or at end of treatment compared with placebo (low certainty).
Flunarizine showed no clear difference in death or dependency at end of compared with placebo (low certainty).
Flunarizine showed no clear difference in death at the end of treatment compared with placebo (low certainty).